GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2101 - 2125** of **4050** in total

« First

‹ Prev

…

81

82

83

84

85

86

87

88

89

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgA	Patient 1	10	moderate	G40696TO	394
IgA	Patient 1	22	moderate	G40696TO	366
IgA	Patient 1	6	moderate	G40696TO	359
IgG	Patient 1	10	moderate	G40696TO	23
IgG	Patient 1	22	moderate	G40696TO	26
IgM	Patient 1	10	moderate	G40696TO	44
IgM	Patient 1	22	moderate	G40696TO	56
IgA	Patient 2	15	mild	G40696TO	328
IgA	Patient 2	24	mild	G40696TO	317
IgG	Patient 2	15	mild	G40696TO	36
IgG	Patient 2	24	mild	G40696TO	30
IgM	Patient 2	15	mild	G40696TO	107
IgM	Patient 2	24	mild	G40696TO	94
IgG	Patient 1	6	moderate	G40696TO	25
IgM	Patient 1	6	moderate	G40696TO	38
IgA	Patient 2	3	mild	G40696TO	303
IgG	Patient 2	3	mild	G40696TO	30
IgM	Patient 2	3	mild	G40696TO	101
IgA	Patient 3	-180	mild	G40696TO	270
IgA	Patient 3	11	mild	G40696TO	399
IgG	Patient 3	-180	mild	G40696TO	46
IgM	Patient 3	-180	mild	G40696TO	86
IgA	Patient 3	4	mild	G40696TO	366
IgG	Patient 3	11	mild	G40696TO	44
IgG	Patient 3	4	mild	G40696TO	36